The American Journal of Managed Care® Launches ‘The Progression of Type 2 Diabetes and the Treatment Options to Manage It’

The expert ‘Peer Exchange’ panel reviews novel agents in the treatment plan for glycemic control in type 2 diabetes

CRANBURY, N.J.--()--The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, presents its most recent “Peer Exchange” panel discussion, “The Progression of Type 2 Diabetes and the Treatment Options to Manage It.” The video series features several experts in the field of diabetes who review novel agents in the treatment plan for glycemic control and discuss their role in treating patients with and without cardiovascular disease.

“Diabetes continues to be a progressive disease and quite a challenge for physicians when providing an adequate treatment plan for their patients,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of AJMC®. “During this educational video series, our experts come together to discuss the similarities and differences between type 1 and type 2 diabetes, along with new treatment options for patients with diabetes.”

This AJMC® “Peer Exchange” panel features four distinguished experts:

  • Dr. Peter L. Salgo, professor of medicine and anesthesiology at Columbia University College of Physicians and Surgeons and associate director of surgical intensive care at NewYork-Presbyterian Hospital, as moderator.
  • Dr. Om P. Ganda, medical director of the Lipid Clinic and chair of the Clinical Oversight Committee at Joslin Diabetes Center.
  • James T. Kenney, RPh, MBA, founder and president of JTKENNEY, LLC.
  • Dr. Helena W. Rodbard, past president of the American College of Endocrinology and past president of the American Association of Clinical Endocrinologists.

The “Peer Exchange” series begins with a discussion on pathophysiology of type 2 diabetes and how it differs from type 1 diabetes, along with its early signs and symptoms. The experts also provide an overview of the treatment approach for diabetes, including the nonpharmacologic approaches to management of type 2 diabetes. Additional segments focus on currently available treatment options, including sodium-glucose cotransporter 2 inhibitors, GLP-1 receptor agonists and dipeptidyl peptidase 4 inhibitors, as well as reviewing available combination therapies.

For more information and to view the video series, click here.

About The American Journal of Managed Care®

The American Journal of Managed Care® (AJMC®) is a multimedia peer-reviewed, MEDLINE-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision makers as they work to promote the efficient delivery of high-quality care. AJMC.com is the essential website for managed care professionals, distributing industry updates daily to leading stakeholders. Other titles in the AJMC® family include The American Journal of Accountable Care®, and two evidence-based series, Evidence-Based Oncology and Evidence-Based Diabetes Management™. These comprehensive offerings bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. To order reprints of articles appearing in AJMC® publications, please contact Gil Hernandez at 609-716-7777, ext. 139.

Contacts

AJMC® Media Contact:
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com

Release Summary

The American Journal of Managed Care® Launches ‘The Progression of Type 2 Diabetes and the Treatment Options to Manage It’

Contacts

AJMC® Media Contact:
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com